Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:484-492
© 2000 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
ACE Gene Polymorphism in Cardiovascular Disease
Meta-Analyses of Small and Large Studies in Whites
From the Department of Clinical Biochemistry (B.A-L., A.T-H.), Herlev University Hospital, and the Department of Clinical Biochemistry (B.G.N.), Glostrup University Hospital, University of Copenhagen, Denmark.
Correspondence to Birgit Agerholm-Larsen, Department of Clinical Biochemistry, Herlev University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark. E-mail balarsen{at}image.dk
Abstract—The objective of this study was to assess the influence of the ACE gene insertion (I)/deletion (D) polymorphism on plasma ACE activity; blood pressure; and risk of myocardial infarction, ischemic heart disease, and ischemic cerebrovascular disease by comparing small and large studies. The meta-analyses are based on a literature search of MEDLINE up until April 1998 and assessment of bibliographies of published studies and reviews. Forty-six studies were selected, including a total of 32 715 white individuals. Plasma ACE activity was increased 40% and 71% for ID and DD versus II in small studies and 21% and 48% in large studies (small versus large: P<0.001 and P<0.001). Blood pressure was not influenced by genotype. Risk of myocardial infarction and ischemic heart disease was increased by 47% and 29%, respectively, for DD versus ID and II genotypes in small studies but not in large studies (small versus large: P<0.001 for risk of myocardial infarction and P=0.01 for risk of ischemic heart disease). Risk of ischemic cerebrovascular disease was not increased either in the small or in the largest study. In conclusion, the ACE gene polymorphism affects plasma ACE activity but not blood pressure and is not associated with increased risk of myocardial infarction, ischemic heart disease, or ischemic cerebrovascular disease in the largest studies.
Key Words: ACE gene insertion • deletion polymorphism • ACE activity • blood pressure • ischemic cardiovascular disease
This article has been cited by other articles:
 |
|
 |
|
  J. B. van der Net, J. van Etten, M. Yazdanpanah, G. M. Dallinga-Thie, J. J.P. Kastelein, J. C. Defesche, R. P. Koopmans, E. W. Steyerberg, and E. J.G. Sijbrands Gene-load score of the renin-angiotensin-aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia Eur. Heart J., June 1, 2008; 29(11): 1370 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zintzaras, G. Raman, G. Kitsios, and J. Lau Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphic Variant as a Marker of Coronary Artery Disease: A Meta-analysis Arch Intern Med, May 26, 2008; 168(10): 1077 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Bonnet, S. Patel, M. Laville, B. Balkau, A. Favuzzi, L. D. Monti, N. Lalic, M. Walker, and on behalf of the European Group for the Study of I Influence of the ACE Gene Insertion/Deletion Polymorphism on Insulin Sensitivity and Impaired Glucose Tolerance in Healthy Subjects Diabetes Care, April 1, 2008; 31(4): 789 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Arnett and for the Writing Group Summary of the American Heart Association's Scientific Statement on the Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1682 - 1686. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Muthumala, H. Montgomery, J. Palmen, J. A. Cooper, and S. E. Humphries Angiotensin-Converting Enzyme Genotype Interacts With Systolic Blood Pressure to Determine Coronary Heart Disease Risk in Healthy Middle-Aged Men Hypertension, August 1, 2007; 50(2): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Marciante, J. C. Bis, M. J. Rieder, A. P. Reiner, T. Lumley, S. A. Monks, C. Kooperberg, C. Carlson, S. R. Heckbert, and B. M. Psaty Renin-Angiotensin System Haplotypes and the Risk of Myocardial Infarction and Stroke in Pharmacologically Treated Hypertensive Patients Am. J. Epidemiol., July 1, 2007; 166(1): 19 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al. Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, June 5, 2007; 115(22): 2878 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Ntzani, E. C. Rizos, and J. P. A. Ioannidis Genetic Effects versus Bias for Candidate Polymorphisms in Myocardial Infarction: Case Study and Overview of Large-Scale Evidence Am. J. Epidemiol., May 1, 2007; 165(9): 973 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kooperberg, J. C. Bis, K. D. Marciante, S. R. Heckbert, T. Lumley, and B. M. Psaty Logic Regression for Analysis of the Association between Genetic Variation in the Renin-Angiotensin System and Myocardial Infarction or Stroke Am. J. Epidemiol., February 1, 2007; 165(3): 334 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. V. Pereira, A. C. F. Nunes, M. Rudnicki, R. Magistroni, A. Albertazzi, A. C. Pereira, and J. E. Krieger Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3155 - 3163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gu, S. Su, D. Ge, S. Chen, J. Huang, B. Li, R. Chen, and B. Qiang Association Study With 33 Single-Nucleotide Polymorphisms in 11 Candidate Genes for Hypertension in Chinese Hypertension, June 1, 2006; 47(6): 1147 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.A. Sayed-Tabatabaei, B.A. Oostra, A. Isaacs, C.M. van Duijn, and J.C.M. Witteman ACE Polymorphisms Circ. Res., May 12, 2006; 98(9): 1123 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Ginsburg, M. P. Donahue, and L. K. Newby Prospects for Personalized Cardiovascular Medicine: The Impact of Genomics J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1615 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. BEDNARSKA-MAKARUK, M. RODO, C. MARKUSZEWSKI, A. ROZENFELD, M. SWIDERSKA, B. HABRAT, and H. WEHR POLYMORPHISMS OF APOLIPOPROTEIN E AND ANGIOTENSIN-CONVERTING ENZYME GENES AND CAROTID ATHEROSCLEROSIS IN HEAVY DRINKERS Alcohol Alcohol., July 1, 2005; 40(4): 274 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F A Sayed-Tabatabaei, A F C Schut, A Arias Vasquez, A M Bertoli-Avella, A Hofman, J C M Witteman, and C M van Duijn Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study J. Med. Genet., January 1, 2005; 42(1): 26 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lin, L. Finn, J. Zhang, T. Young, and E. Mignot Angiotensin-converting Enzyme, Sleep-disordered Breathing, and Hypertension Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1349 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Casas, A. D. Hingorani, L. E. Bautista, and P. Sharma Meta-analysis of Genetic Studies in Ischemic Stroke: Thirty-two Genes Involving Approximately 18 000 Cases and 58 000 Controls Arch Neurol, November 1, 2004; 61(11): 1652 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. van Onna, A. A. Kroon, A. J.H.M. Houben, D. Koster, M. P.A. Zeegers, L. H.G. Henskens, A. W. Plat, H. E.J.H. Stoffers, and P. W. de Leeuw Genetic Risk of Atherosclerotic Renal Artery Disease: The Candidate Gene Approach in a Renal Angiography Cohort Hypertension, October 1, 2004; 44(4): 448 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Kammerer, N. Gouin, P. B. Samollow, J. F. VandeBerg, J. E. Hixson, S. A. Cole, J. W. MacCluer, and L. D. Atwood Two Quantitative Trait Loci Affect ACE Activities in Mexican-Americans Hypertension, February 1, 2004; 43(2): 466 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Ye, S Dhillon, R Seear, L Dunleavey, L B Day, W Bannister, I N M Day, and I Simpson Epistatic interaction between variations in the angiotensin I converting enzyme and angiotensin II type 1 receptor genes in relation to extent of coronary atherosclerosis Heart, October 1, 2003; 89(10): 1195 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Schieffer and H. Drexler The race for ACE: A simple answer to the controversial puzzle of angiotensin-converting enzyme (ACE) polymorphisms J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1962 - 1963. [Full Text] [PDF]
|
|
|
|
|
|
A. C. Pereira, G. F.A. Mota, R. S. Cunha, F. L. Herbenhoff, J. G. Mill, and J. E. Krieger Angiotensinogen 235T Allele "Dosage" Is Associated With Blood Pressure Phenotypes Hypertension, January 1, 2003; 41(1): 25 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-M. Taute, C. Glaser, R. Taute, and H. Podhaisky Progression of Atherosclerosis in Patients with Peripheral Arterial Disease as a Function of Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism Angiology, July 1, 2002; 53(4): 375 - 382. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Egger, S. Ebrahim, and G. D. Smith Where now for meta-analysis? Int. J. Epidemiol., February 1, 2002; 31(1): 1 - 5. [Full Text] [PDF]
|
|
|
|
|
|
S. Fava, J. Azzopardi, S. Ellard, and A. T. Hattersley ACE Gene Polymorphism as a Prognostic Indicator in Patients With Type 2 Diabetes and Established Renal Disease Diabetes Care, December 1, 2001; 24(12): 2115 - 2120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Arcaro, A. Solini, T. Monauni, A. Cretti, B. Brunato, A. Lechi, R. Fellin, M. Caputo, C. Cocco, E. Bonora, et al. ACE Genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1313 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Harrap and S. Petrou Utility of genetic approaches to common cardiovascular diseases Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H1 - H6. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Sethi, A. Tybjaerg-Hansen, M.-L. M. Gronholdt, R. Steffensen, P. Schnohr, and B. G. Nordestgaard Angiotensinogen Mutations and Risk for Ischemic Heart Disease, Myocardial Infarction, and Ischemic Cerebrovascular Disease: Six Case-Control Studies from the Copenhagen City Heart Study Ann Intern Med, May 15, 2001; 134(10): 941 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Rossi, S. Taddei, A. Virdis, L. Ghiadoni, G. Albertin, S. Favilla, I. Sudano, A. C. Pessina, and A. Salvetti Exclusion of the ACE D/I Gene Polymorphism as a Determinant of Endothelial Dysfunction Hypertension, February 1, 2001; 37(2): 293 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Batalla, R. Alvarez, J. R. Reguero, S. Hevia, G. Iglesias-Cubero, V. Alvarez, A. Cortina, P. Gonzalez, M. M. Celada, A. Medina, et al. Synergistic Effect between Apolipoprotein E and Angiotensinogen Gene Polymorphisms in the Risk for Early Myocardial Infarction Clin. Chem., December 1, 2000; 46(12): 1910 - 1915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Crisan and J. Carr Angiotensin I-Converting Enzyme: Genotype and Disease Associations J. Mol. Diagn., August 1, 2000; 2(3): 105 - 115. [Full Text]
|
|
|
|
|
|
B. Schieffer ACE Gene Polymorphism and Coronary Artery Disease : A Question of Persuasion or Statistical Confusion? Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 281 - 282. [Full Text] [PDF]
|
|